Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.
2.

 Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.

Reggiardo MV, Fay F, Tanno M, García-Camacho G, Bottaso O, Ferretti S, Godoy A, Guerrita C, Paez M, Tanno F, Ruffinengo O, Benetti S, García Borrás SE, Rossi MC, Vorobioff J, Bessone F, Tanno H.

Ann Hepatol. 2012 Sep-Oct;11(5):658-66.

3.

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.

Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T.

Hepatology. 1999 Oct;30(4):1054-8.

PMID:
10498659
4.

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.

Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.

PMID:
19032460
5.

Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.

Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC; Trent Hepatitis C Study Group.

Gut. 2004 Mar;53(3):451-5.

6.

Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection.

Costa LB, Ferraz ML, Perez RM, Ferreira AS, Matos CA, Lanzoni VP, Silva AE.

Braz J Infect Dis. 2002 Oct;6(5):219-24.

PMID:
12495603
7.

Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.

Howell J, Sawhney R, Angus P, Fink M, Jones R, Wang BZ, Visvanathan K, Crowley P, Gow P.

Transpl Infect Dis. 2013 Dec;15(6):588-99. doi: 10.1111/tid.12134. Epub 2013 Sep 13.

PMID:
24028328
8.

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.

Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, Wiselka M, Norris S.

Gut. 2003 Jul;52(7):1035-40.

9.

Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study.

Li JF, Liu S, Ren F, Liu M, Wu HL, Chen Y, Zou HB, Bai L, Li Y, Zheng SJ, Duan ZP.

Int J Infect Dis. 2014 Oct;27:49-53. doi: 10.1016/j.ijid.2014.07.003. Epub 2014 Aug 26.

10.

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study.

Wright M, Goldin R, Fabre A, Lloyd J, Thomas H, Trepo C, Pradat P, Thursz M; HENCORE collaboration.

Gut. 2003 Apr;52(4):574-9.

11.

There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.

Souza AR, Tovo CV, Mattos AA, Chaves S.

Braz J Med Biol Res. 2008 Mar;41(3):223-8. Epub 2007 Dec 20.

12.

Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.

Myers RP, Hilsden RJ, Lee SS.

J Viral Hepat. 2001 Jul;8(4):249-55.

PMID:
11454175
13.

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.

Hepatology. 1999 Jan;29(1):250-6.

PMID:
9862874
14.

Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?

Guido M, Bortolotti F, Leandro G, Jara P, Hierro L, Larrauri J, Barbera C, Giacchino R, Zancan L, Balli F, Crivellaro C, Cristina E, Pucci A, Rugge M.

Am J Gastroenterol. 2003 Mar;98(3):660-3.

PMID:
12650803
15.

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, Opolon P, Poynard T.

Gastroenterology. 1999 Feb;116(2):378-86.

PMID:
9922319
16.

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J.

J Hepatol. 2001 May;34(5):730-9.

PMID:
11434620
17.

Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.

Marabita F, Aghemo A, De Nicola S, Rumi MG, Cheroni C, Scavelli R, Crimi M, Soffredini R, Abrignani S, De Francesco R, Colombo M.

Hepatology. 2011 Oct;54(4):1127-34. doi: 10.1002/hep.24503. Epub 2011 Aug 19.

PMID:
21721028
18.

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence.

Verbaan H, Widell A, Bondeson L, Andersson K, Eriksson S.

J Viral Hepat. 1998 Jan;5(1):43-51.

PMID:
9493516
19.

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.

Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, Norkrans G, Wejstål R.

J Viral Hepat. 2002 May;9(3):235-41.

PMID:
12010513
20.

Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.

Mariné-Barjoan E, Saint-Paul MC, Pradier C, Chaillou S, Anty R, Michiels JF, Sattonnet C, Ouzan D, Dellamonica P, Tran A; Registre des Ponctions-Biopsies Hépatiques.

AIDS. 2004 Nov 5;18(16):2163-70.

PMID:
15577649

Supplemental Content

Support Center